IL 4 Rhesus Macaque

Interleukin-4 Rhesus Macaque Recombinant
Shipped with Ice Packs
In Stock

Description

Biological Functions and Immune Roles

IL-4 Rhesus Macaque exhibits conserved immunological functions across primates:

  • B-Cell Regulation: Enhances IgE/IgG1 secretion, MHC class II expression, and CD23 (FcεRII) upregulation .

  • T-Cell Differentiation: Drives naïve CD4+ T cells toward Th2 phenotypes, promoting anti-parasitic and allergic responses .

  • Innate Immunity: Activates mast cells, eosinophils, and monocytes while stimulating epithelial cell proliferation .

Key Functional Data:

  • PBMC Stimulation: PMA/ionomycin-treated rhesus PBMCs secrete 95.34 pg/mL IL-4, compared to 47.30 pg/mL in cynomolgus macaques .

  • Cytokine Correlations: Elevated IL-6, IP-10, and MCP-1 during SFTSV infection correlate with activated CD4+/CD8+ T cells and monocytes, highlighting IL-4’s indirect role in inflammatory cascades .

Detection and Quantification

  • ELISA Kits: The Abcam SimpleStep ELISA® detects IL-4 in plasma, serum, and cell culture supernatants with a sensitivity of 2.2 pg/mL and a range of 15.6–1000 pg/mL .

  • Antibodies: The QS-4 monoclonal antibody (U-CyTech) cross-reacts with rhesus, cynomolgus, and baboon IL-4, enabling flow cytometry and immunohistochemistry .

Experimental Models

  • SFTSV Infection: Rhesus macaques infected with SFTSV show transient leukopenia and thrombocytopenia, with IL-4-linked Th2 responses modulating viral persistence in lymphoid tissues .

Clinical and Mechanistic Insights

  • Allergy and Asthma: IL-4 overexpression in macaques drives eosinophil recruitment and IgE production, mirroring human allergic pathways .

  • Vaccine Development: IL-4-neutralizing antibodies (e.g., QS-4) are used to dissect Th1/Th2 balances in HIV/SIV vaccine trials .

Product Specs

Introduction
Interleukin 4 (IL4) is a cytokine with diverse roles, produced by activated T cells. It binds to the interleukin 4 receptor, which also interacts with IL13. This shared receptor contributes to the functional overlap between IL4 and IL13. IL4 signaling relies heavily on STAT6, a signal transducer and activator of transcription, for its immune regulatory effects. The genes encoding IL3, IL4, IL5, IL13, and CSF2 are clustered on chromosome 5q, with IL4 positioned close to IL13. Notably, IL4, IL13, and IL5 are co-regulated by multiple long-range regulatory elements spanning over 120 kilobases on this chromosome. Two alternatively spliced transcripts of the IL4 gene produce distinct isoforms.
Description
Recombinant Rhesus Macaque IL-4, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 129 amino acids, resulting in a molecular weight of 14.9 kDa. The purification of IL4 Rhesus Macaque is achieved using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation
Lyophilized from a 0.2 µm filtered solution in 1xPBS, pH 7.4 at a concentration suitable for lyophilization.
Solubility
To reconstitute the lyophilized Interleukin-4, it is recommended to dissolve it in sterile 18 MΩ-cm H2O to a concentration of at least 100 µg/ml. This solution can then be further diluted in other aqueous solutions as needed.
Stability
Lyophilized Interleukin-4 remains stable at room temperature for up to 3 weeks. However, for long-term storage, it should be kept desiccated at temperatures below -18°C. After reconstitution, IL4 should be stored at 4°C for a maximum of 2-7 days. For extended storage, freeze-thaw cycles should be avoided, and the solution should be kept at temperatures below -18°C.
Purity
Purity exceeds 97.0% as determined by: (a) Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analysis. (b) Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) analysis.
Biological Activity
The ED₅₀, determined by the dose-dependent stimulation of TF1 cells, is less than 0.2 ng/ml. This translates to a specific activity greater than 5.0 x 10⁶ IU/mg.
Synonyms
Interleukin-4, IL-4, B-cell stimulatory factor 1, BSF-1, Lymphocyte stimulatory factor 1, IL4.
Source
Escherichia Coli.
Amino Acid Sequence
HNCHIALREI IETLNSLTEQ KTLCTKLTIT DILAASKNTT EKETFCRAAT VLRQFYSHHE KDTRCLGATA QQFHRHKQLI RFLKRLDRNL WGLAGLNSCP VKEANQSTLE DFLERLKTIM REKYSKCSS.

Q&A

What is the primary biological role of IL-4 in rhesus macaque immune responses?

IL-4 in rhesus macaques serves as a pleiotropic cytokine critical for Th2 cell differentiation, B-cell activation, and IgE/IgG1 antibody production. It regulates CD23 expression on lymphocytes and monocytes and modulates myeloid-derived suppressor cells (MDSCs) during immune responses .

How is IL-4 quantified in rhesus macaque studies?

IL-4 levels are measured using sandwich-based ELISA kits validated for cross-reactivity between human and rhesus macaque IL-4 (Accession Number: P51492). These kits detect IL-4 in plasma, serum, and cell culture supernatants with a sensitivity of 5 pg/ml and a dynamic range of 5–1,600 pg/ml .

What experimental models use IL-4 in rhesus macaque research?

Key models include:

  • Vaccine studies: IL-4 peaks transiently after NYVAC or SFV immunizations, correlating with Th2 responses .

  • Infectious disease models: Pertussis infection induces systemic IL-6 and TNF-α but minimal IL-4, suggesting Th1/Th17 dominance .

  • Immune modulation: MDSCs transiently expand post-vaccination, suppressing T-cell proliferation via arginase-1 and IL-10 .

How does IL-4 homology between humans and rhesus macaques impact translational research?

Rhesus macaque IL-4 shares ~40% amino acid identity with human IL-4, necessitating species-specific reagents (e.g., anti-rhesus IL-4 antibodies) . Cross-reactivity in ELISA kits requires validation .

SpeciesIL-4 Homology (%)Functional SpecificityKey Challenges
Human100Broad Th2 responsesCross-reactivity in NHP studies
Rhesus~40Species-restricted activityLimited commercial reagents
Mouse~45Distinct T-cell regulationPoor cross-species applicability

How do IL-4 responses differ between vaccine and infection models in rhesus macaques?

  • Vaccine responses: IL-4 peaks transiently after NYVAC boosts, declining within weeks .

  • Infection models: Pertussis infection shows negligible IL-4 elevation, favoring Th1/Th17 cytokines like IL-6 and TNF-α .
    This dichotomy highlights IL-4’s context-dependent role in immune polarization.

What methodological challenges arise when interpreting IL-4 data in rhesus macaque studies?

  • Cross-reactivity: ELISA kits detecting both human and rhesus IL-4 require validation for specificity .

  • Temporal dynamics: IL-4 peaks rapidly post-vaccination but declines, necessitating frequent sampling .

  • Tissue-specific responses: MDSCs transiently infiltrate vaccine sites but not lymph nodes, complicating systemic vs. local IL-4 effects .

How can IL-4 be optimized in rhesus macaque models for HIV/SIV vaccine development?

IL-4’s role in Th2 skewing may counteract Th1-biased responses critical for SIV/HIV control. Strategies include:

  • Co-stimulatory molecules: Enhancing CD28/CD95 signaling to balance Th2 and Th1 responses .

  • PD-1 blockade: Targeting Tfh cells (PD-1hiCD4+), which express Bcl6 and ICOS, to modulate IL-4-driven B-cell help .

Why do IL-4 responses vary between rhesus macaque and human vaccine trials?

FactorRhesus MacaqueHuman
Pol-specific IFN-γHigher magnitude and persistence Lower, transient responses
IL-4 kineticsRapid peak, rapid decline post-vaccination Similar kinetics but lower magnitude
Priming agentsAlphavirus vectors enhance Gag/Nef responses DNA priming preferred for Env targeting

How to reconcile reports of IL-4’s transient vs. persistent effects in rhesus macaque studies?

IL-4’s short half-life (~15 kDa) explains rapid clearance post-vaccination . Persistent Th2 responses may involve alternative mediators (e.g., IL-13) or memory B-cell activation .

Why does pertussis infection suppress IL-4 despite MDSC expansion?

Pertussis-induced MDSCs upregulate IL-10 and arginase-1 but not IL-4, favoring Th1/Th17 responses . This contrasts with vaccine-induced MDSCs, which may transiently secrete IL-4 to regulate inflammation .

Optimizing IL-4 detection in rhesus macaque samples

  • ELISA protocol: Use 2-fold serum/plasma dilutions and validate with recombinant rhesus IL-4 standards .

  • Timing: Sample at 24–48 hours post-vaccination/infection to capture IL-4 peaks .

  • Controls: Include human IL-4 standards to assess cross-reactivity .

Integrating IL-4 with multi-cytokine profiling

CytokineRole in Rhesus Macaque ModelsIL-4 Interaction
IL-10MDSC-mediated suppression Antagonistic to IL-4’s Th2 effects
IFN-γTh1 responses (e.g., SIV/HIV vaccines) Competes with IL-4 for T-cell polarization
IL-6Systemic inflammation (pertussis) Synergizes with IL-4 in B-cell activation

Future Research Directions

  • Epigenetic regulation: Investigate IL-4 promoter methylation in rhesus macaque T cells during SIV infection.

  • Single-cell profiling: Map IL-4-producing cells (e.g., Th2, Tfh) using scRNA-seq in vaccine vs. infection models.

  • Therapeutic targeting: Test IL-4 blockade to enhance Th1 responses in HIV vaccines or IL-4 agonists in allergy models.

Product Science Overview

Structure and Function

IL-4 is a monomeric protein with a molecular weight ranging from approximately 13 kDa to 18 kDa . The recombinant version of IL-4 from Rhesus Macaque is produced in E. coli and is a single, non-glycosylated polypeptide chain containing 129 amino acids, with a molecular mass of 14.9 kDa . The mature rhesus IL-4 shares 97%, 93%, and 93% amino acid sequence identity with baboon, chimpanzee, and human IL-4, respectively .

Biological Activity

IL-4 exerts its effects through two receptor complexes, primarily influencing the differentiation of naive helper T cells (Th0 cells) to Th2 cells . It is involved in the stimulation of activated B-cell and T-cell proliferation, and the differentiation of B cells into plasma cells. IL-4 also enhances the secretion and cell surface expression of IgE and IgG1 .

Applications

Recombinant IL-4 from Rhesus Macaque is used in various research applications, including cell proliferation assays, where it has been shown to stimulate the proliferation of TF-1 human erythroleukemic cells . It is also used in studies related to immune responses and cytokine signaling pathways.

Production and Purification

The recombinant IL-4 is produced using E. coli expression systems and is purified through proprietary chromatographic techniques . The protein is typically lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. The carrier-free version does not contain BSA, which is recommended for applications where the presence of BSA could interfere .

Stability and Storage

The recombinant IL-4 is shipped at ambient temperature and should be stored at -20 to -70 °C upon receipt. It is stable for 12 months from the date of receipt when stored as supplied. After reconstitution, it should be stored under sterile conditions at 2 to 8 °C for up to 1 month or at -20 to -70 °C for up to 3 months .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.